Iteos Therapeutics Inc (ITOS) — Cash Flow Reinvestment Rate
Iteos Therapeutics Inc (ITOS) has a Cash Flow Reinvestment Rate of 2.50x as of December 2024, reinvesting $13.77 Million (capex $152.00K plus investments $13.62 Million) from operating cash flow of $5.50 Million. See ITOS free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Iteos Therapeutics Inc Cash Flow Reinvestment Rate (2021–2021)
Historical reinvestment intensity for Iteos Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Iteos Therapeutics Inc operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Iteos Therapeutics Inc (2021–2021)
Year-by-year capital reinvestment analysis for Iteos Therapeutics Inc. See ITOS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.00x | $2.42 Million | $513.14 Million | $1.18 Million | — |